In a similar manner, our findings match earlier studies in which an upregulation of PON2 was identified in a group of patients who suffered from pediatric acute lymphoblastic leukemia (ALL) with poor outcome prognosis [28]. Here, PON2 is linked to acute lymphoblastic leukemia.